Literature DB >> 26141480

Effects of Domperidone on QT Interval in Children with Gastroesophageal Reflux Disease.

Thitima Ngoenmak1, Suporn Treepongkaruna2, Yuthapong Buddharaksa3, Anant Khositseth4.   

Abstract

BACKGROUND: Domperidone has been widely used in children with gastroesophageal reflux disease (GERD). Studies on the effects of domperidone on corrected QT interval (QTc) in young children are limited. Our aim was to study the effect of domperidone on the repolarization abnormalities assessed by electrocardiogram (ECG) in young children.
METHODS: ECG was performed in children <2 years of age before and after taking domperidone orally 0.3 mg/kg three times/day for at least a 1 week period. Each ECG was reviewed and QT, RR, and Tpeak to Tend intervals (TpTe) were measured to calculate the QTc and TpTe/QT ratio.
RESULTS: A total of 22 patients (12 male) with a median age of 8.5 months (1-24 months) were enrolled. Most patients (59.1%) were under 1 year of age. The median baseline QTc (410 milliseconds, 350-450 milliseconds) was not significantly different from the QTc after taking domperidone (410 milliseconds, 320-560 milliseconds), p = 0.159. Only two patients showed a QTc increase ≥450 milliseconds. The baseline TpTe interval and TpTe/QT (105 milliseconds, 60-170 milliseconds and 0.27 milliseconds, 0.15-0.43 milliseconds) were significantly greater than the TpTe interval and TpTe/QT in children after taking domperidone (90 milliseconds, 60-140 milliseconds and 0.22 milliseconds, 0.15-0.29 milliseconds), p = 0.001 and 0.004, respectively.
CONCLUSIONS: Our data demonstrate that domperidone treatment over a short-term period in children <2 years of age did not lengthen QTc significantly; however, QTc increased ≥450 milliseconds in two patients with concomitant lansoprazole. Routine baseline and follow-up ECG may not be necessary in each individual case receiving only domperidone.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  QT interval; children; domperidone; gastroesophageal reflux disease

Mesh:

Substances:

Year:  2015        PMID: 26141480     DOI: 10.1016/j.pedneo.2015.03.015

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  4 in total

1.  Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Authors:  Rachel Rosen; Yvan Vandenplas; Maartje Singendonk; Michael Cabana; Carlo DiLorenzo; Frederic Gottrand; Sandeep Gupta; Miranda Langendam; Annamaria Staiano; Nikhil Thapar; Neelesh Tipnis; Merit Tabbers
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-03       Impact factor: 2.839

2.  A meta-analysis on the cardiac safety profile of domperidone compared to metoclopramide.

Authors:  Serhat Bor; Mesut Demir; Oktay Ozdemir; Kivanc Yuksel
Journal:  United European Gastroenterol J       Date:  2018-09-10       Impact factor: 4.623

3.  Effects of domperidone in combination with omeprazole in the treatment of chronic superficial gastritis.

Authors:  Fengxiu Wang; Xiaoqi Zhang; Jinqiang Wang
Journal:  Pak J Med Sci       Date:  2017 Mar-Apr       Impact factor: 1.088

4.  Cardiovascular alterations in rats with Parkinsonism induced by 6-OHDA and treated with Domperidone.

Authors:  Laís D Rodrigues; Leandro F Oliveira; Lucas Shinoda; Carla A Scorza; Jean Faber; Henrique B Ferraz; Luiz R G Britto; Fulvio A Scorza
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.